oral

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

Off-Label Antidepressant Use in Pediatric Patients with Autism

By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences -- Psychotropic medications are…

12 years ago

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

Anticoagulation in Pregnant Women: Which Medications are Safe?

By: Diana Gritsenko, PharmD Candidate 2015 - Multiple complications can arise during pregnancy. While venous thromboembolism (VTE) has a prevalence…

12 years ago

FDA-Approved Afrezza: An Inhaled Alternative to Injectable Insulin?

By: Elissa Tam, PharmD Candidate c/o 2015 - Patients with Type 1 or Type 2 diabetes who cannot control their…

12 years ago

Grastek®: FDA Approves New Sublingual Immunotherapy for Allergies

By: Kevin Lin, PharmD Candidate c/o 2015 - This April, the FDA approved three sublingual immunotherapies for pollen induced allergic…

12 years ago

The Dangers of Intrathecal Baclofen

By: Ada Seldin, Staff Editor - Intrathecal baclofen (ITB) is indicated for the treatment of intractable spasticity caused by spinal…

12 years ago

I Have a Problem

By: Sang Hyub Kim, DPM Candidate c/o 2018, New York College of Podiatric Medicine - I was diagnosed with ulcerative…

12 years ago

The Use of Topical Opioid Treatment for Pressure Ulcer Wounds

By: Katharine Cimmino, Editor-in-Chief - Pressure ulcers can be a painful condition decreasing the quality of life of patients and…

12 years ago

New Strides in Lupus Treatment

By: Daniel Mathan, PharmD Candidate c/o 2016, Anita Kachappilly, PharmD Candidate c/o 2016, & Amrita Singh, PharmD Candidate c/o 2015 -…

12 years ago

Riociguat (Adempas®) New Drug for Pulmonary Hypertension

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

The Increasing Roles of Pharmacists in Transplant Outcomes

By: Jenny Park, PharmD Candidate c/o 2015 - Medication adherence is a big part of a patient’s success in managing…

12 years ago

The Use of Methadone in Neuropathic Pain

By: Neal Shah, PharmD, MD/PhD Student c/o 2021, West Virginia University School of Medicine - Methadone is a powerful long-acting…

12 years ago

The Blunt Truth

By: Katharine Cimmino, Editor-in-Chief - Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a…

12 years ago

Phi Lambda Sigma’s 12th Annual Healthy Halloween

By: Taryn Mondiello, PharmD Candidate c/o 2015 - Halloween came early this year to St. John’s University and to the…

13 years ago

Possible Inhaled Option for Diabetics

By: Sang Hyo Kim, Staff Editor - Near the end of December, the pharmaceutical company, MannKind Corp, will submit their…

13 years ago

Still a Long Road Ahead for New Hepatitis C Treatment

By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…

13 years ago

Zecuity(TM): Novel Treatment Option for Migraines

By: Arya Mathew, PharmD Candidate c/o 2014 -  About twelve percent of the U.S. population suffers from migraines, affecting adult…

13 years ago

Nature’s Remedy… in a More Palatable Dosage Form

By: Davidta Brown, Staff Editor - Pathogenic bacteria have been enemies to human health for centuries. As recently as last…

13 years ago

New Treatment for a Deficiency in Iron-Supplement Therapies

By: Davidta Brown, Staff Editor - For the estimated 7.5 million individuals in the United States living with iron deficiency…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

Ketoconazole No More

By: Hayeon Na, Co-Copy Editor [Content-Focused] - The Food and Drug Administration (FDA) announced on July 26th that oral dosage…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

HIV Test: Making a Difference

By: Sang Hyo Kim, Staff Editor - On June 27, 2013, the Centers for Disease Control and Prevention (CDC), AIDS.gov,…

13 years ago

Novel Virus, Standard Vigilance

By: Davidta Brown, Staff Editor - When the seasons transition from winter into spring every year, healthcare providers brace for…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Compounding at a Crossroads: New Boundaries in the Aftermath of Tragedy?

Davidta Brown, PharmD Candidate c/o 2017 -      The debate on the nature of compounding practice and the extent to…

13 years ago

FDA Approves Dimethyl Fumarate for Treatment of Relapsing Forms of Multiple Sclerosis

By: Andy Zhang, PharmD Candidate c/o 2015 - On March 28, 2013, the U.S. Food and Drug Administration announced the…

13 years ago

FDA Approves New Drug ‘Tofacitinib’ for Rheumatoid Arthritis

By: Erica Dimitropoulos, Senior Staff Editor - Rheumatoid arthritis is a painful and often debilitating autoimmune disease characterized by symmetric…

13 years ago

Flu Season 2012-2013: Rising Opportunities for Pharmacists

By: Fawad Piracha, Pharm. D Candidate c/o 2016 - The 2012-2013 influenza season has developed into one of the greatest…

13 years ago

New P2Y12 Antagonist on the Rise

By Nancy Rizkalla, PharmD candidate c/o 2015 -        Percutaneous coronary intervention (PCI) with subsequent stent implantation is a highly…

13 years ago

FDA Approves New Indication for Botox (OnabotulinumtoxinA) for Urinary Incontinence

By: Bethsy Jacob, PharmD Candidate 2014 - On January 18, 2013, the U.S. Food and Drug Administration (FDA) announced a…

13 years ago

New Healthcare Law Concerning Birth Control Causes Debate

By: Katie Cimmino, Pharm D. Candidate c/o 2015 -  With the start of the New Year the French government is…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Adverse Events from Ingestion of OTC Eye Drops and Nasal Sprays

By Tasnima Nabi, PharmD Candidate c/o 2016 - The FDA has issued warnings on accidental ingestion of over-the-counter eye drops…

14 years ago

Safety and Efficacy of Atropine for Salivary Hypersecretion

By: Elsa Thomas, PharmD Candidate c/o 2013 - Atropine is an anticholinergic used to treat various conditions, such as bradycardia,…

14 years ago

New Drug Review: Tofacitinib (Xeljanz®)

By: Jessica Lee, PharmD Candidate c/o 2013 - Rheumatoid arthritis (RA) is an autoimmune disease in which the immune system…

14 years ago

Ivacaftor (KalydecoTM): Targeting the Core of Cystic Fibrosis

By: Eugene Kolomiyets, PharmD Candidate c/o 2013, AMSCOP at LIU - Cystic fibrosis (CF) is an autosomal recessive disease caused…

14 years ago

Medications Causing Body Temperature Fluctuations

By: Elsa Thomas, Pharm.D. c/o 2013 - Human body uses various complex mechanisms to maintain its body temperature within a…

14 years ago

Brand Vs. Generic: What Every Prescriber Should Know

By: Marina Yermolayeva, PharmD Candidate c/o 2013 - “I’m allergic to the generic; I need the brand name medication,” is…

14 years ago

Quick Update: Triptan Pharmacology

By: Neal Shah, Co-Editor-In-Chief - Migraines can be “classic” or “common.”  While all migraines feature unilateral, pulsating headaches, classic migraines…

14 years ago

The Role of N-Acetylcysteine in Contrast Induced Nephropathy

By: Neal Shah, Co-Editor-In-Chief - Contrast dyes enhance imaging for computer tomography (CT), magnetic resonance (MR), and X-rays.1  Dyes usually…

14 years ago

Meet the new Beta 3 Agonist: Mirabegron (Myrbetriq®)

By: Steve P. Soman - Mirabegron (Mybetriq®), known also by the brand name Betanis®in Japan, is a new once daily…

14 years ago

Artificial Saliva Agents in Xerostomia

By: Neal Shah, Co-Editor-in-Chief - Xerostomia, commonly known as dry mouth, is an anti-muscarinic side effect of numerous medications.  Antidepressants,…

14 years ago

Matching Challenge: Look-Alike, Sound-Alikes

By: Addolorata Ciccone, Pharm.D. Candidate c/o 2013 - The following medications are easily confused.  Try to match each one with…

14 years ago

Proton Pump Inhibitor Use and Complications

By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 - We see proton pump inhibitors (PPIs) used in many medication regimens, but…

14 years ago

CHF, a Rare but Serious Presentation of Graves’ disease

By: James Schurr, Pharm.D. Candidate c/o 2014 - Graves’ disease is an autoimmune disorder that results in a state of…

14 years ago